Sponsor or institution
Clinical trials and research at Arvinas Inc.
As of November 12, 2026, Find a Trial lists 2 clinical trials run by Arvinas Inc. that are recruiting, at sites in 5 countries (most in United States (2), Australia (1), Canada (1)). By phase: Phase 1 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 5Countries
All recruiting trials (2)
-
ARV-6723 alone or with pembrolizumab in adults with advanced solid tumors
This study tests ARV-6723, by itself or with pembrolizumab, to see if it is safe and could help the immune system fight advanced solid tumors in adults.
-
Testing ARV-393 for advanced non-Hodgkin lymphoma
This study is testing a new oral drug called ARV-393 to see if it can help slow down or stop tumor growth in people with advanced non-Hodgkin lymphoma that hasn't responded to other treatments.
Quick answers
How many clinical trials run by Arvinas Inc. are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 5 countries. The most sites are in United States (2 trials), Australia (1 trial), Canada (1 trial), Denmark (1 trial), Spain (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.